{"entity":{"id":"nct05065957","kind":"trial","name":"Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer","aka":[],"tldr":"A phase 2/3 trial testing D07001 in biliary tract cancer, now recruiting.","summary":"Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer is a phase 2/3 interventional study registered as NCT05065957, led by InnoPharmax, and recruiting on the registry. Official title: Open-Label, Multicenter, Phase II/III Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer After Gemcitabine and Cisplatin-Based Treatment Failure. Planned enrolment is 180 participants (estimated). The study started in 2022-03-29 and primary completion is expected in 2026-07. No results have been posted on ClinicalTrials.gov.","status":"recruiting","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov NCT05065957","url":"https://clinicaltrials.gov/study/NCT05065957"}],"tags":["ctgov-ingest"],"related":[],"cancers":["cholangiocarcinoma"],"sections":[],"technologies":[],"targets":[],"drugs":["d07001"],"companies":["innopharmax"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05065957","phase":"2/3","setting":"Open-Label, Multicenter, Phase II/III Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer After Gemcitabine and Cisplatin-Based Treatment Failure","sponsor":"InnoPharmax","started":"2022-03-29","startedType":"actual","enrolled":180,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05065957/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"}],"drug":[{"id":"d07001","kind":"drug","name":"D07001","route":"/drugs/d07001/"}],"company":[{"id":"innopharmax","kind":"company","name":"InnoPharmax","route":"/companies/innopharmax/"}]}}